VLOOP DIN 02560887
Health Canada record
| Active ingredient(s) | ETONOGESTREL 11 MG; ETHINYL ESTRADIOL 3.474 MG |
|---|---|
| Dosage form | Ring (Slow-Release) |
| Route | Vaginal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G02BB01 VAGINAL RING WITH PROGESTOGEN AND ESTROGEN |
| Original market date | |
| Current status date | 05-Sep-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating I (2026-09-16).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ETONOGESTREL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02520028 | HALOETTE | SEARCHLIGHT PHARMA INC | Ring (Slow-Release) | ETONOGESTREL 11.7 MG; ETHINYL ESTRADIOL 2.7 MG | Marketed |
| 02499509 | NEXPLANON | ORGANON CANADA INC. | Implant | ETONOGESTREL 68 MG | Marketed |
| 02253186 | NUVARING | ORGANON CANADA INC. | Ring (Slow-Release) | ETONOGESTREL 11.4 MG; ETHINYL ESTRADIOL 2.6 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35965 | 2025-09-05 | Abbreviated New Drug Submission (ANDS) |
International API supply for ETONOGESTREL
2 valid EDQM Certificates of Suitability from 2 holders. 6 active FDA Drug Master Files.
Request a quote for VLOOP